Crispr Therapeutics $CRSP had a strong run up in late 2017 into February 2018. After hitting a higher of $61.24 per share, price started to enter a period of consolidation. It started with a bearish correction swing down to almost $40.00. After such a sharp slide (34% down), it should not be a surprise if price started to "congest" or consolidate with higher lows and lower highs - essentially a triangle.CRSP Daily Chart(click to enlarge)Triangle:- The daily chart shows the triangle forming as volatility normalizes after the noted surge and 34% correction.- Using the triangle perspective, $44.00 is an important triangle support. It is also in a previous support/resistance pivot area. - A break below $44 could open up the $40 level as well as the $34.00 handle. - A hold above $44 with a break above $50.35 would maintain the triangle scenario, which is neutral-bullish with upside back to the $61.24 mark with the prospect of higher highs especially if overall market sentiment turns bullish.